Advertisement
Advertisement

FMS

FMS logo

Fresenius Medical Care AG

25.53
USD
Sponsored
+0.67
+2.70%
Jul 30, 12:30 UTC -4
Open

FMS Earnings Reports

Positive Surprise Ratio

FMS beat 27 of 42 last estimates.

64%

Next Report

Next Week
Date of Next Report
Aug 04, 2026
Estimate for Q2 26 (Revenue/ EPS)
$4.84B
/
$1.05
Implied change from Q1 26 (Revenue/ EPS)
+4.99%
/
+15.38%
Implied change from Q2 25 (Revenue/ EPS)
+1.05%
/
+15.38%

Fresenius Medical Care AG earnings per share and revenue

On May 05, 2026, FMS reported earnings of 0.91 USD per share (EPS) for Q1 26, missing the estimate of 0.99 USD, resulting in a -8.34% surprise. Revenue reached 4.61 billion, compared to an expected 4.66 billion, with a -0.94% difference. The market reacted with a -10.86% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 3 analysts forecast an EPS of 1.05 USD, with revenue projected to reach 4.84 billion USD, implying an increase of 15.38% EPS, and increase of 4.99% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Thermo Fisher Scientific, Inc.
Report Date
Jul 23, 2026 For Q2 26
Estimate
$5.76
Actual
$6.03
Surprise
+4.54%
logo
Intuitive Surgical Inc.
Report Date
Jul 16, 2026 For Q2 26
Estimate
$2.55
Actual
$2.80
Surprise
+9.79%
logo
Edwards Lifesciences Corp
Report Date
Jul 23, 2026 For Q2 26
Estimate
$0.76
Actual
$0.78
Surprise
+2.13%
logo
IQVIA Holdings Inc.
Report Date
Jul 28, 2026 For Q2 26
Estimate
$3.06
Actual
$3.15
Surprise
+2.92%
logo
Glaukos Corporation
Report Date
Jul 29, 2026 For Q2 26
Estimate
-$0.22
Actual
-$0.14
Surprise
+38.52%
logo
Axogen, Inc. Common Stock
Report Date
Jul 29, 2026 For Q2 26
Estimate
$0.12
Actual
$0.12
Surprise
-5.88%
logo
Opko Health Inc.
Report Date
Jul 27, 2026 For Q2 26
Estimate
-$0.08
Actual
-$0.01
Surprise
+87.62%
logo
Integra LifeSciences Holdings
Report Date
Jul 29, 2026 For Q2 26
Estimate
$0.49
Actual
$0.56
Surprise
+13.57%
logo
Beta Bionics, Inc. Common Stock
Report Date
Jul 29, 2026 For Q2 26
Estimate
-$0.60
Actual
-$0.53
Surprise
+12.77%
FAQ
For Q1 2026, Fresenius Medical Care AG reported EPS of $0.91, missing estimates by -8.34%, and revenue of $4.61B, -0.94% below expectations.
The stock price moved down -10.86%, changed from $22.65 before the earnings release to $20.19 the day after.
The next earning report is scheduled for Aug 04, 2026.
Based on 3 analysts, Fresenius Medical Care AG is expected to report EPS of $1.05 and revenue of $4.84B for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement